TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against Enterobacteriaceae
Kiyoko Fujita, Iichiro Takata, Ippei Yoshida, Hirotoshi Okumura, Katsumasa Otake, Hajime Takashima, Hiroyuki Sugiyama
Topics & Concepts
In vivoKlebsiella pneumoniaeMicrobiologyCiprofloxacinEnterobacteriaceaeAntibioticsAntibacterial activityCarbapenemPharmacologyBacteriaChemistryEscherichia coliBiologyBiochemistryBiotechnologyGeneticsGeneAntibiotic Resistance in BacteriaPneumocystis jirovecii pneumonia detection and treatmentHIV/AIDS drug development and treatment